Chemomab Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Chemomab Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Chemomab Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Chemomab Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $260 | 99 | 2.63 |